Pediatric Dermatology 2009-01-01

Systematized contact dermatitis and montelukast in an atopic boy.

Mari Paz Castanedo-Tardan, Mercedes E González, Elizabeth A Connelly, Kelly Giordano, Sharon E Jacob

Index: Pediatr. Dermatol. 26(6) , 739-43, (2009)

Full Text: HTML

Abstract

Upon ingestion, the artificial sweetener, aspartame is metabolized to formaldehyde in the body and has been reportedly associated with systemic contact dermatitis in patients exquisitely sensitive to formaldehyde. We present a case of a 9-year-old Caucasian boy with a history of mild atopic dermatitis that experienced severe systematized dermatitis after being started on montelukast chewable tablets containing aspartame. Patch testing revealed multiple chemical sensitivities which included a positive reaction to formaldehyde. Notably, resolution of his systemic dermatitis only occurred with discontinuation of the montelukast chewables.


Related Compounds

Related Articles:

Convenient QSAR model for predicting the complexation of structurally diverse compounds with β-cyclodextrins

2009-01-01

[Bioorg. Med. Chem. 17 , 896-904, (2009)]

Synergistic topical application of salt-processed Phellodendron amurense and Sanguisorba officinalis Linne alleviates atopic dermatitis symptoms by reducing levels of immunoglobulin E and pro-inflammatory cytokines in NC/Nga mice.

2015-11-01

[Mol. Med. Report. 12 , 7657-64, (2015)]

Statistical design for formulation optimization of hydrocortisone butyrate-loaded PLGA nanoparticles.

2014-06-01

[AAPS PharmSciTech 15(3) , 569-87, (2014)]

[Hydrocortisone 17-butyrate (Locoid), a thirty-year ongoing innovative drug].

2006-02-01

[Rev. Med. Liege. 61(2) , 128-30, (2006)]

Corticosteroid solubility and lipid polarity control release from solid lipid nanoparticles.

2010-05-05

[Int. J. Pharm. 390(1) , 53-60, (2010)]

More Articles...